Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Diverse Activity of IL-17+ Cells in Chronic Skin and Mucosa Graft-Versus-Host Disease.

Klimczak A, Suchnicki K, Sedzimirska M, Lange A.

Arch Immunol Ther Exp (Warsz). 2019 Oct;67(5):311-323. doi: 10.1007/s00005-019-00549-2. Epub 2019 Jun 8.

2.

Hemophagocytic Lymphohistiocytosis (HLH) Triggered by Wasp Venom Immunotherapy Is Rare but Noteworthy.

Nittner-Marszalska M, Kosińska M, Suchnicki K, Rzeszutko M, Pomorska M, Durek G, Panaszek B.

J Investig Allergol Clin Immunol. 2019 Feb;29(1):49-51. doi: 10.18176/jiaci.0322. No abstract available.

3.

Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.

Bogunia-Kubik K, Mizia S, Polak M, Gronkowska A, Nowak J, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Koclęga A, Sędzimirska M, Suchnicki K, Duda D, Lange J, Mordak-Domagała M, Kościńska K, Jędrzejczak WW, Kaczmarek B, Hellmann A, Kucharska A, Kowalczyk J, Drabko K, Warzocha K, Hałaburda K, Tomaszewska A, Mika-Witkowska R, Witkowska A, Goździk J, Mordel A, Wysoczańska B, Jaskula E, Lange A; POLISH DONOR–RECIPIENT STUDY GROUP.

Cytokine. 2015 Dec;76(2):182-186. doi: 10.1016/j.cyto.2015.05.001. Epub 2015 May 14.

PMID:
25982843
4.

CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor.

Bogunia-Kubik K, Mizia S, Gronkowska A, Nowak J, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Koclęga A, Sędzimirska M, Suchnicki K, Duda D, Lange J, Mordak-Domagała M, Kościńska K, Węzik S, Jędrzejczak WW, Kaczmarek B, Hellmann A, Kucharska A, Kowalczyk J, Drabko K, Warzocha K, Mika-Witkowska R, Goździk J, Lange A.

Br J Haematol. 2015 Oct;171(2):285-288. doi: 10.1111/bjh.13387. Epub 2015 Mar 30. No abstract available.

PMID:
25823722
5.

Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.

Jaskula E, Dlubek D, Tarnowska A, Lange J, Mordak-Domagala M, Suchnicki K, Sedzimirska M, Borowik A, Mizia S, Lange A.

Viruses. 2015 Mar 23;7(3):1391-408. doi: 10.3390/v7031391.

6.

Glomerular lesion and increased cytokine gene expression in renal tissue in patients with decompensated nephrotic syndrome due to chronic GvHD.

Kaminska D, Bernat B, Vakulenko O, Kuzniar J, Tyran B, Suchnicki K, Lange A, Mazanowska O, Halon A, Klinger M.

Ren Fail. 2010 May;32(4):510-4. doi: 10.3109/08860221003664256.

PMID:
20446793
8.

HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis.

Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A.

Int J Immunogenet. 2006 Apr;33(2):135-40.

PMID:
16611259
9.

IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.

Karabon L, Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Lange A.

Hum Immunol. 2005 Jun;66(6):700-10. Epub 2005 Mar 19.

PMID:
15993715
10.

Combined association between IFN-gamma 3,3 homozygosity and DRB1*03 in Löfgren's syndrome patients.

Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Mlynarczewska A, Lange A.

Immunol Lett. 2004 Feb 15;91(2-3):127-31.

PMID:
15019280
12.

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.

Czyz J, Hellmann A, Dziadziuszko R, Hansz J, Goździk J, Hołowiecki J, Stella-Hołowiecka B, Kachel Ł, Knopińska-Posłuszny W, Nagler A, Meder J, Walewski J, Lampka E, Sułek K, Sawicki W, Lange A, Forgacz K, Suchnicki K, Pacuszko T, Skotnicki A, Mensah P, Jurczak W, Kuliczkowski K, Wróbel T, Mazur G, Dmoszyńska A, Wach M, Robak T, Warzocha K.

Bone Marrow Transplant. 2002 Jul;30(1):29-34.

13.

HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis.

Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A.

Tissue Antigens. 2001 Jan;57(1):87-90.

PMID:
11169267
14.

G-CSF-mobilized leukapheresis products: cellular characteristics and clinical performance in allografting.

Dłubek D, Pacuszko T, Suchnicki K, Lange A.

J Hematother. 1999 Apr;8(2):157-66.

PMID:
10349909
15.

Hematopoietic cell transplantation: activity and results of the BMT Unit K.Dłuski Hosp./Inst.Immun. & Exp.Therapy, Wrocław, Poland.

Sedzimirska M, Pacuszko T, Klimczak A, Kichler O, Suchnicki K, Bocheńska J, Mróz E, Dłubek D, Karabon L, Lange A.

Bone Marrow Transplant. 1998 Dec;22 Suppl 4:S57-9. No abstract available.

PMID:
9916637
16.

Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis.

Seitzer U, Swider C, Stüber F, Suchnicki K, Lange A, Richter E, Zabel P, Müller-Quernheim J, Flad HD, Gerdes J.

Cytokine. 1997 Oct;9(10):787-90.

PMID:
9344512
17.

Serum interferon-gamma and C-reactive protein levels as predictors of acute graft-vs-host disease in allogeneic hematopoietic precursor cell (marrow or peripheral blood progenitor cells) recipients.

Lange A, Karabon L, Klimczak A, Dłubek D, Bogunia-Kubik K, Swider C, Suchnicki K.

Transplant Proc. 1996 Dec;28(6):3522-5. No abstract available.

PMID:
8962369
18.

Cytokines, adhesion molecules (E-selectin and VCAM-1) and graft-versus-host disease.

Lange A, Klimczak A, Karabon L, Suchnicki K.

Arch Immunol Ther Exp (Warsz). 1995;43(2):99-105. Review.

PMID:
8744723
19.

Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia.

Wachowiak J, Bettoni C, Lange A, Malicki J, Kaczmarek-Kanold M, Głuszak B, Suchnicki K, Daszkiewicz P, Ebell W.

Acta Haematol Pol. 1995;26(4):377-84.

PMID:
8571739

Supplemental Content

Loading ...
Support Center